A previous study on glioblastoma showed that knockdown of MerTK disrupted the rounded morphology of glioma cells with a decrease in tumor stem cell markers, such as Sox2 and Nestin, indicating that MerTK could maintain cells in an undifferentiated state.29 Here, SOX2 is linked to central nervous system cancer.